These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 27235935)

  • 1. Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats.
    Coelho A; Oliveira R; Cruz F; Cruz CD
    Exp Neurol; 2016 Nov; 285(Pt B):159-166. PubMed ID: 27235935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
    Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury.
    Munoz A; Somogyi GT; Boone TB; Smith CP
    Neurourol Urodyn; 2011 Sep; 30(7):1376-81. PubMed ID: 21509809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal administration of botulinum toxin type A improves urinary bladder function and reduces pain in rats with cystitis.
    Coelho A; Oliveira R; Rossetto O; Cruz CD; Cruz F; Avelino A
    Eur J Pain; 2014 Nov; 18(10):1480-9. PubMed ID: 24756904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action.
    Coelho A; Cruz F; Cruz CD; Avelino A
    Eur Urol; 2012 Jun; 61(6):1178-84. PubMed ID: 22306320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of early intravesical administration of resiniferatoxin to spinal cord-injured rats in neurogenic detrusor overactivity.
    Oliveira R; Coelho A; Franquinho F; Sousa MM; Cruz F; D Cruz C
    Neurourol Urodyn; 2019 Aug; 38(6):1540-1550. PubMed ID: 31180583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A; Mearini E; Del Zingaro M; Porena M
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?
    Huynh Le Maux A; Pignol B; Behr-Roussel D; Blachon JL; Chabrier PE; Compagnie S; Picaut P; Bernabé J; Giuliano F; Denys P
    Toxins (Basel); 2015 Dec; 7(12):5462-71. PubMed ID: 26694464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals.
    Cruz CD; Charrua A; Vieira E; Valente J; Avelino A; Cruz F
    Exp Neurol; 2008 Dec; 214(2):301-8. PubMed ID: 18824169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.
    Chen G; Liao L
    Int Urol Nephrol; 2011 Sep; 43(3):655-62. PubMed ID: 21110094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review.
    Linsenmeyer TA
    J Spinal Cord Med; 2013 Sep; 36(5):402-19. PubMed ID: 23941788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurogenic detrusor overactivity - botulinum toxin type A injections improve quality of life].
    Braun M
    Aktuelle Urol; 2013 May; 44(3):177-8. PubMed ID: 23712270
    [No Abstract]   [Full Text] [Related]  

  • 13. Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity.
    Kaviani A; Khavari R
    Urol Clin North Am; 2017 Aug; 44(3):463-474. PubMed ID: 28716326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore.
    Tow AM; Toh KL; Chan SP; Consigliere D
    Ann Acad Med Singap; 2007 Jan; 36(1):11-7. PubMed ID: 17285181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients.
    Chen YC; Kuo HC
    Neurourol Urodyn; 2014 Jan; 33(1):129-34. PubMed ID: 23494629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury.
    Jia C; Liao LM; Chen G; Sui Y
    Spinal Cord; 2013 Jun; 51(6):487-90. PubMed ID: 23357928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin treatment for bladder dysfunction.
    Santos-Silva A; da Silva CM; Cruz F
    Int J Urol; 2013 Oct; 20(10):956-62. PubMed ID: 23634720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of trigonal BTX-A injections for children with neurological detrusor overactivity secondary to spinal cord injury.
    Hui C
    J Pediatr Surg; 2020 Dec; 55(12):2736-2739. PubMed ID: 32571538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011.
    Kanai A; Zabbarova I; Oefelein M; Radziszewski P; Ikeda Y; Andersson KE
    Neurourol Urodyn; 2012 Mar; 31(3):300-8. PubMed ID: 22275187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity.
    Hui C; Keji X; Chonghe J; Ping T; Rubiao O; Jianweng Z; Xiangrong D; Liling Z; Maping H; Qingqing L; Qiuling L; Jiebing H; Tanghai H
    Spinal Cord; 2016 Jan; 54(1):46-50. PubMed ID: 26261074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.